Daniil Gataulin
Stock Analyst at Chardan Capital
(0)
# 4667
Out of 5,297 analysts
83
Total ratings
20.97%
Success rate
-20.14%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
FBRX Forte Biosciences | Maintains: Buy | 64 61 | 7.34 | 731.06% | 4 | Apr 1, 2025 | |
QURE uniQure | Maintains: Strong Buy | 27 38 | 10.61 | 258.15% | 1 | Apr 1, 2025 | |
CLSD Clearside Biomedical | Maintains: Buy | 6 6 | 0.93 | 545.16% | 4 | Mar 28, 2025 | |
UBX Unity Biotechnology | Maintains: Buy | 6 4 | 1.03 | 288.35% | 3 | Mar 25, 2025 | |
CGTX Cognition Therapeuti... | Maintains: Buy | 11 8 | 0.42 | 1804.76% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 52 52 | 7.09 | 633.43% | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 14 | 13.51 | 3.63% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 28 | 18.31 | 52.92% | 5 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 33 33 | 5.38 | 513.38% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 7 | 0.69 | 914.49% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 36 | 6.37 | 465.15% | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 3 | 1.25 | 140% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 4 40 | 4.29 | 832.4% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 220 220 | 2.68 | 8108.96% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 22 13 | n/a | n/a | 2 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Sep 28, 2022 |